Behavioural Health, FDA Approval and Trials - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Behavioural Health

FDA Approval

Trials

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

pharmaphorum

APRIL 23, 2021

The company has been pushing for more reimbursement of its three marketed DTx products in the US following a first FDA approval in 2017. Pear noted that the grant comes at a time when many communities are seeing increased demand for behavioural health and recovery services amid the ongoing coronavirus pandemic.

FDA Approval

FDA Approval Behavioural Health Clinical Trials Clinical Trials

FDA green lights Oxehealth vital signs monitoring software

pharmaphorum

APRIL 6, 2021

UK digital health company Oxehealth has claimed FDA approval for software that can be used to remotely measure vital signs like heart and breathing rates from a camera feed. . million people, as well as assisted living facilities, general hospitals, behavioural health providers and custodial care settings.

Nurses

Nurses Behavioural Health FDA Approval Clinical Trials

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

FDA green lights Oxehealth vital signs monitoring software

Stay Connected